The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a hernia.It was reported that after implant, the patient experienced recurrence, infection, adhesions, abscess, fistula, and organ damage.Post-operative patient treatment included small bowel resection, revision surgery/debridement, mesh removal, wound vac, and mesh failure.
|
Additional information was received indicating this device was implanted on a different date and has been moved to a separate pe, 706568523.No further reports will be sent for this product event on this pe.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|